No results for ‘’
Entero Healthcare Solutions Ltd
₹1089.40
(1.46%)
Mon, 22 Jun 2026, 09:23 am
Distribution Services
Medical Distributors
24.5KEntero Healthcare Solutions Price to Sales Ratio (P/S)
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 91.09 | 52.22 |
| Price to book ratio | 0 | 0 | 0 | 2.62 | 2.87 |
| Price to sales ratio | 0 | 0 | 0 | 0.91 | 0.97 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 |
| Enterprise value | 0 | 0 | 0 | 3011Cr | 4921Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 26.92 | 28.59 |
| Debt to equity ratio | 0.42 | 0.63 | 0.74 | 0.21 | 0.22 |
| Return on equity % | 0 | -5.72 | -2 | 3.50 | 5.64 |
Entero Healthcare Solutions Ltd Price to Sales Ratio
The Entero Healthcare Solutions Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Entero Healthcare Solutions Ltd's valuation, profitability, and overall financial performance. Tracking the Entero Healthcare Solutions Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Entero Healthcare Solutions Ltd (NSE: ENTERO, BSE: 544122) is currently trading at ₹1089.40, with a market capitalization of ₹4751.53Cr. As a leading company in the Distribution services sector and Medical distributors industry, monitoring the Entero Healthcare Solutions Ltd Price to Sales Ratio is essential for fundamental analysis.
Entero Healthcare Solutions Ltd Price to Sales Ratio Current Value
The current Entero Healthcare Solutions Ltd Price to Sales Ratio stands at 0.97.
The latest Entero Healthcare Solutions Ltd Price to Sales Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Entero Healthcare Solutions Ltd Price to Sales Ratio Historical Trend
The Entero Healthcare Solutions Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 0.97
- 2023: 0.91
- 2022: 0
- 2021: 0
- 2020: 0
The recent rise in Entero Healthcare Solutions Ltd Price to Sales Ratio suggests strengthening valuation trends and improving market sentiment.
What Entero Healthcare Solutions Ltd Price to Sales Ratio Indicates for Investors
The Entero Healthcare Solutions Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Entero Healthcare Solutions Ltd Price to Sales Ratio Analysis Summary
The Entero Healthcare Solutions Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Entero Healthcare Solutions Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Entero Healthcare Solutions Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.